Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Martin, Delaney"'
Autor:
Martin Delaney
Publikováno v:
AIDS research and human retroviruses. 26(5)
Autor:
Roger J. Pomerantz, David M. Margolis, Douglas D. Richman, Warner C. Greene, Martin Delaney, Daria J. Hazuda
Publikováno v:
Science (New York, N.Y.). 323(5919)
Although combination therapy for HIV infection represents a triumph for modern medicine, chronic suppressive therapy is required to contain persistent infection in reservoirs such as latently infected CD4+lymphocytes and cells of the macrophage-monoc
Autor:
Martin, Delaney
Publikováno v:
Project Inform perspective.
Autor:
Martin, Delaney
Publikováno v:
Project Inform perspective.
Autor:
Martin, Delaney
Publikováno v:
Project Inform perspective.
Publikováno v:
Positively aware : the monthly journal of the Test Positive Aware Network. 19(1)
Autor:
Michael R. Price, Barbara Starrett, Robert Mayer, Larry Waites, Vera S. Byers, Martin Delaney, Robert W. Baldwin, Alan S. Levin, Richard A Robins, J. A. Clegg
Publikováno v:
Aids. 4:1189-1196
Trichosanthin, a ribosomal inhibitor protein, blocks HIV replication in lymphocytes and macrophages. This agent was used to treat 51 patients with advanced HIV disease in a dose-escalation study in which three injections were administered over a 9-21
Autor:
Martin, Delaney
Publikováno v:
Research initiative, treatment action : RITA. 12(2)
Autor:
Martin Delaney
Publikováno v:
Retrovirology
The development of multi-drug combination therapy for treatment of HIV disease is considered one of the great success stories of modern medicine. In a period of approximately ten years, the death rate from HIV disease was reduced by 50 to 80% and cha
Publikováno v:
Ethics and the Pharmaceutical Industry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75b3bcd5026ecbfed5302bbb7bf4a213
https://doi.org/10.1017/cbo9780511610769.024
https://doi.org/10.1017/cbo9780511610769.024